Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Handbook of Clinical Neurology|January 12, 2026
Role of complement in neurologic autoimmunities: Why need to target complement activation for effective immunotherapyMarinos C Dalakas, Peter J Späth
Clinical Reviews in Allergy & Immunology|January 5, 2006
Anti-inflammatory effect of intravenous immunoglobulin mediated through modulation of complement activationHans U Lutz, Peter J Späth
Advances in Experimental Medicine and Biology|August 21, 2012
Naturally occurring antibodies/autoantibodies in polyclonal immunoglobulin concentratesPeter J Späth, Hans U Lutz
Archivum Immunologiae Et Therapiae Experimentalis|September 18, 2016
Clinical Use and Therapeutic Potential of IVIG/SCIG, Plasma-Derived IgA or IgM, and Other Alternative Immunoglobulin PreparationsPeter J Späth, Christoph Schneider, Stephan von Gunten
Clinical Reviews in Allergy & Immunology|January 5, 2006
Virus safety of intravenous immunoglobulin: future challengesNicola Boschetti, Martin Stucki, Peter J Späth, et al.
Frontiers in Immunology|February 21, 2015
On the dark side of therapies with immunoglobulin concentrates: the adverse eventsPeter J Späth, Guido Granata, Fabiola La Marra, et al.
International Immunopharmacology|August 28, 2016
Polyclonal IgM and IgA block in vitro complement deposition mediated by anti-ganglioside antibodies in autoimmune neuropathiesMakoto Sudo, Kazuki Miyaji, Peter J Späth, et al.
Plos One|September 27, 2014
Different IVIG glycoforms affect in vitro inhibition of anti-ganglioside antibody-mediated complement depositionMakoto Sudo, Yoshiki Yamaguchi, Peter J Späth, et al.
Frontiers in Immunology|January 8, 2015
Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in europeJacqueline Kerr, Isabella Quinti, Martha Eibl, et al.
Pageof 2